Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
about
Hepatoblastoma: A Need for Cell Lines and Tissue Banks to Develop Targeted Drug TherapiesOpen access chemical probes for epigenetic targetsPre-Clinical Models of Diffuse Intrinsic Pontine GliomaFuture Clinical Trials in DIPG: Bringing Epigenetics to the ClinicSpatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeuticsPre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma ModelsDiffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic TargetsLong-term survival of an infant with diffuse brainstem lesion diagnosed by prenatal MRI: a case report and review of the literature.Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma.A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG).Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas.Pediatric high-grade glioma: biologically and clinically in need of new thinkingSmall molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cellsTargeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas.Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain InhibitionDevelopment of a DIPG Orthotopic Model in Mice Using an Implantable Guide-Screw System.Combination therapy design for maximizing sensitivity and minimizing toxicity.Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma.Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders.Mutations in chromatin machinery and pediatric high-grade gliomaCombined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinomaDual Inhibition of PI3K/AKT and MEK/ERK Pathways Induces Synergistic Antitumor Effects in Diffuse Intrinsic Pontine Glioma Cells.Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model.Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal diseaseThe international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease.Glioblastoma targeted therapy: updated approaches from recent biological insights.An epigenetic gateway to brain tumor cell identity.Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1.Advances in the molecular genetics of gliomas - implications for classification and therapy.AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic modelsDiffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.Oncogenic Mechanisms of Histone H3 Mutations.Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies.The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children.Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine GliomaNew Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M.Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma.Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel.Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma.
P2860
Q54898646-AA6FA1B8-A665-4897-9619-1EE57199259DQ54930394-0FD3E835-D29C-47CB-894C-F3FA695295B5Q54930396-B4174093-B6CF-4A0B-BB49-67B6C10B115CQ54930397-F3D5B654-1C35-406D-A592-6F8E3A470C05Q54930398-2BC0A674-0478-411E-A6BF-37056FF6D79AQ54952936-D8F39CE9-A9F5-440F-AA76-6E6C68DA9503Q54970734-A5FA1F43-C96E-42C2-A771-D35D42FDF0EAQ54970735-87AAA4B9-1562-4AA0-B0E2-EA05306C6F1FQ54970736-3CA191BA-035B-4B19-8DAE-51D83ECB4B65Q54970747-F95F4E30-0316-49B7-8BC2-0690B7823E23Q54993418-4580617D-2C6A-4E83-AA5A-B9E49754E136Q54993419-5E3E0BBD-E00F-4C10-885C-CCA6CFE3F944
P1343
Q26751517-D7CE069C-F894-4617-A779-B288353E2F49Q26781872-827CF823-9AAF-4B73-8E59-1BC6FA90CBA2Q26799976-63C7B7A2-8910-4700-A4E8-4F9DD21EFD25Q26801858-1DC95408-B1ED-4353-9DF4-E276A27AD6C4Q27317083-09D2E38C-5265-42B0-A627-62DCFA4DC2E4Q28468398-0683A79D-C961-4DCA-98E8-E18B9F46D522Q30251385-C5480A61-ADBC-442F-8EF8-D7E87ED34C92Q31048538-888C738C-0529-4D7F-B048-291417203F92Q33568113-D4040368-CDD7-498B-AF82-B10C424709A1Q33615351-79242B6C-193B-42A1-B6AC-685F47969772Q33737472-65AC2A28-4D17-4EAD-A9FC-7D97B44417DFQ33777868-33CD95D8-E1E1-4C11-A314-AA523EF03EBBQ33798642-F381E4CF-A2EF-4807-B570-CDBD8474B01FQ34552042-C10326C2-630C-4446-8D9D-43F7FF581E52Q35824823-7F6FFA88-3985-4765-84F5-6BC50D6F7B2EQ36130555-72A171DB-5E2F-47F0-AE1E-7AC3B6546A22Q36255670-82B8A200-55CF-4ED6-A61F-B2BE6E172EC6Q36329307-1B019DD9-7CC7-4D54-B297-12267AC0ABE0Q36380213-06582AEA-AB33-4A13-986D-7760DA9749FFQ36578816-20D728E6-929E-4BDD-A8E9-004F3E3F14F3Q36716785-DEFCCCCA-C076-404F-8F3B-333797C02380Q37123636-5CEB116A-763E-427A-ADAE-BDD988C76DE1Q37635839-56092494-5D23-4FFD-83E7-39B6358C3097Q37669168-406BFBE2-7235-4355-A0B6-D0721BFE6596Q37736041-AF8FCBB8-B67A-4188-BF06-DDA170A4B5C6Q38374138-72CAEBCA-C7C8-4695-A3FF-169BB9F90534Q38597700-0D271E5A-39CB-4D62-86F9-7D14081DF705Q38682159-CAD8181F-5BE9-4BEE-949C-83B587EB3570Q38752174-B1114775-9CEF-4203-AC80-A9C34ED605AAQ38777058-F08CB2B0-EC47-4004-9A2C-34E520F6FD75Q38813184-E0340E25-6DDC-435E-8048-0C7A2514EE55Q38963434-1A0C4527-2067-4FAE-A4ED-877858F37FE3Q39013655-4346B159-6D0E-4BAA-BF10-484890447F4AQ39069889-DBE894EB-5E45-4DDF-9EB2-818337245B2CQ39074023-03D3024E-372B-4237-8EAC-25DBEFF30F9FQ39154575-E5DD1342-20C1-4BD4-AD63-A32D95DEBE46Q39167472-E3982634-85A0-417B-9C71-E21CFB0047C4Q39236500-394CF24A-ED07-44BC-A859-993688208D26Q39965737-55C0EE5B-5553-4BFB-8DBE-C8CA5CADA81FQ41109977-295CA0BB-A758-4BBA-A3D4-4F6E4CE94983
P2860
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
@ast
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
@en
type
label
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
@ast
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
@en
prefLabel
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
@ast
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
@en
P2093
P2860
P4510
P50
P921
P3181
P356
P1433
P1476
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
@en
P2093
Anitha Ponnuswami
Catherine S Grasso
Charles Keller
Dannis G van Vuurden
Elaine C Huang
Eric H Raabe
Esther Hulleman
Jinu Abraham
Katherine E Warren
P2860
P2888
P3181
P356
10.1038/NM.3855
P407
P577
2015-06-01T00:00:00Z
P6179
1001212323